IDEXX Laboratories Inc. 8-K Report: Key Updates as of May 7, 2025

Based on the provided section of the financial report, here are the key extracted insights:
- Company Identification:
- Name: IDEXX Laboratories Inc.
- CIK (Central Index Key): 0000874716
- Trading Symbol: IDXX
- Stock Exchange: NASDAQ
- Report Type:
- Filing Type: 8-K (a report of unscheduled material events or corporate changes)
- Filing Date:
- Date of Filing: May 7, 2025
- Company Address:
- Headquarters: One IDEXX Drive, Westbrook, ME 04092, USA
- Contact Number: 207-556-0300
- Financial Information:
- Common Stock: The company has common stock with a par value of $0.10 per share.
- Period Covered:
- Reporting Period: The report covers a single date, May 7, 2025, indicating a specific event or update rather than a full fiscal period.
- Regulatory Information:
- SEC File Number: 000-19271
- IRS Number: 01-0393723
- Context:
- The document appears to be structured in XBRL format, indicating it is meant for electronic filing and analysis.
Summary:
This section of the financial report provides essential details about IDEXX Laboratories Inc., including its identification information, the nature of the filing (8-K), and specific dates and contact details. The report indicates a significant event or update related to the company as of May 7, 2025, but does not provide detailed financial metrics or disclosures within the provided text. For further insights, the actual content of the 8-K filing would need to be analyzed.